发明名称 PHARMACEUTICAL FORMULATION
摘要 PURPOSE: A pharmaceutical formulation containing atorvastatin and irbesartan is provided to effectively prevent and treat hypertension, hyperlipidemia and their complication. CONSTITUTION: A pharmaceutical formulation of which release is controlled comprises a immediate release compartment containing atorvastatin as a pharmacologically active ingredient, its pharmaceutically acceptable salt, or its isomer, and a sustained release compartment containing irbesartan as pharmacologically active ingredient, its pharmaceutically acceptable salt or its isomer. The sustained release compartment contains osmosis controlling agent and is coated with semi-permeable coating substrate. The pharmaceutical formulation is used in the form of matrix.
申请公布号 KR20090114328(A) 申请公布日期 2009.11.03
申请号 KR20090037380 申请日期 2009.04.29
申请人 HANALL PHARMACEUTICAL COMPANY LTD. 发明人 KIM, SUNG WUK;JUN, SUNG SOO;LEE, AH RAM;CHOI, JIN WON
分类号 A61K9/22;A61K9/52;A61K47/38;A61P9/12 主分类号 A61K9/22
代理机构 代理人
主权项
地址